These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 24404331)

  • 1. Intercellular Lipid Mediators and GPCR Drug Discovery.
    Im DS
    Biomol Ther (Seoul); 2013 Nov; 21(6):411-22. PubMed ID: 24404331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New intercellular lipid mediators and their GPCRs: an update.
    Im DS
    Prostaglandins Other Lipid Mediat; 2009 Sep; 89(3-4):53-6. PubMed ID: 19442546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Many Roles of Lysophospholipid Mediators and Japanese Contributions to This Field.
    Takagi Y; Nishikado S; Omi J; Aoki J
    Biol Pharm Bull; 2022; 45(8):1008-1021. PubMed ID: 35908884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel lysophosphoplipid receptors: their structure and function.
    Makide K; Uwamizu A; Shinjo Y; Ishiguro J; Okutani M; Inoue A; Aoki J
    J Lipid Res; 2014 Oct; 55(10):1986-95. PubMed ID: 24891334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological tools for lysophospholipid GPCRs: development of agonists and antagonists for LPA and S1P receptors.
    Im DS
    Acta Pharmacol Sin; 2010 Sep; 31(9):1213-22. PubMed ID: 20729877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Druggable Lipid GPCRs: Past, Present, and Prospects.
    Mizuno H; Kihara Y
    Adv Exp Med Biol; 2020; 1274():223-258. PubMed ID: 32894513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging lysophospholipid mediators, lysophosphatidylserine, lysophosphatidylthreonine, lysophosphatidylethanolamine and lysophosphatidylglycerol.
    Makide K; Kitamura H; Sato Y; Okutani M; Aoki J
    Prostaglandins Other Lipid Mediat; 2009 Sep; 89(3-4):135-9. PubMed ID: 19427394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Knowledge on the Biology of Lysophosphatidylserine as an Emerging Bioactive Lipid.
    Omi J; Kano K; Aoki J
    Cell Biochem Biophys; 2021 Sep; 79(3):497-508. PubMed ID: 34129148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'Crystal' Clear? Lysophospholipid Receptor Structure Insights and Controversies.
    Blaho VA; Chun J
    Trends Pharmacol Sci; 2018 Nov; 39(11):953-966. PubMed ID: 30343728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic insights into mediator lipidomics.
    Hla T
    Prostaglandins Other Lipid Mediat; 2005 Sep; 77(1-4):197-209. PubMed ID: 16099404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ras-MAP kinase signaling by lysophosphatidic acid and other G protein-coupled receptor agonists.
    Kranenburg O; Moolenaar WH
    Oncogene; 2001 Mar; 20(13):1540-6. PubMed ID: 11313900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysophospholipid receptors in drug discovery.
    Kihara Y; Mizuno H; Chun J
    Exp Cell Res; 2015 May; 333(2):171-177. PubMed ID: 25499971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The actions and metabolism of lysophosphatidylinositol, an endogenous agonist for GPR55.
    Yamashita A; Oka S; Tanikawa T; Hayashi Y; Nemoto-Sasaki Y; Sugiura T
    Prostaglandins Other Lipid Mediat; 2013 Dec; 107():103-16. PubMed ID: 23714700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards selective lysophospholipid GPCR modulators.
    Archbold JK; Martin JL; Sweet MJ
    Trends Pharmacol Sci; 2014 May; 35(5):219-26. PubMed ID: 24746475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A glance at G-protein-coupled receptors for lipid mediators: a growing receptor family with remarkably diverse ligands.
    Kostenis E
    Pharmacol Ther; 2004 Jun; 102(3):243-57. PubMed ID: 15246248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysophospholipids--receptor revelations.
    Hla T; Lee MJ; Ancellin N; Paik JH; Kluk MJ
    Science; 2001 Nov; 294(5548):1875-8. PubMed ID: 11729304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging roles for lysophospholipid mediators in pregnancy.
    Nagamatsu T; Iwasawa-Kawai Y; Ichikawa M; Kawana K; Yamashita T; Osuga Y; Fujii T; Schust DJ
    Am J Reprod Immunol; 2014 Aug; 72(2):182-91. PubMed ID: 24689547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Advances in Structure, Function, and Pharmacology of Class A Lipid GPCRs: Opportunities and Challenges for Drug Discovery.
    Krishna Deepak RNV; Verma RK; Hartono YD; Yew WS; Fan H
    Pharmaceuticals (Basel); 2021 Dec; 15(1):. PubMed ID: 35056070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysophospholipid interactions with protein targets.
    Parrill AL
    Biochim Biophys Acta; 2008 Sep; 1781(9):540-6. PubMed ID: 18501204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological effects of lysophospholipids.
    Rivera R; Chun J
    Rev Physiol Biochem Pharmacol; 2008; 160():25-46. PubMed ID: 18481029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.